Although previous studies have shown that the percentage of CD117+ erythroid abnormalities (obtained by flow cytometry) can be used for the diagnosis of MDS, the reduced proportion of CD117+ expression in CD105+NEC in patients with MA is the first to be proposed7,8. The gene discussed is KIT; the disease is myelodysplastic syndrome.